RecruitingPhase 2NCT07636811
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Sponsor: Alnylam Pharmaceuticals
Indianapolis, IN · +3 more sites
Alzheimer's Disease clinical trials in Indianapolis, IN
18 recruiting alzheimer's disease studies with a site in Indianapolis, IN.
All trials in Indianapolis, IN · All Alzheimer's Disease trials
RecruitingPhase 3NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Sponsor: Bristol-Myers Squibb
Indianapolis, IN · +30 more sites
RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Indianapolis, IN · +41 more sites
RecruitingPhase not listedNCT00869817
Dominantly Inherited Alzheimer Network (DIAN)
Sponsor: Washington University School of Medicine
Indianapolis, IN · +7 more sites
RecruitingNot applicableNCT05643144
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Sponsor: Indiana University
Indianapolis, IN
RecruitingPhase 4NCT07633470
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Sponsor: Alpha Cognition, Inc
Fort Wayne, IN · Indianapolis, IN · +18 more sites
RecruitingPhase 1NCT05231785
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Sponsor: Alnylam Pharmaceuticals
Indianapolis, IN · +1 more sites
RecruitingPhase 2 / Phase 3NCT07284472
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Sponsor: Exciva GmbH
Indianapolis, IN · +8 more sites
RecruitingPhase 2 / Phase 3NCT05552157
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Sponsor: Washington University School of Medicine
Indianapolis, IN · +12 more sites
RecruitingPhase 2 / Phase 3NCT06647498
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Sponsor: Washington University School of Medicine
Indianapolis, IN · +12 more sites
RecruitingPhase 3NCT07602582
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Sponsor: Eli Lilly and Company
Indianapolis, IN · +50 more sites
RecruitingPhase not listedNCT04165109
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Sponsor: University of Southern California
Indianapolis, IN · +17 more sites
RecruitingNot applicableNCT07486037
Caring for Caregivers of Individuals With Alzheimer's Disease
Sponsor: Indiana University
Indianapolis, IN
RecruitingNot applicableNCT05573490
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Sponsor: Indiana University
Indianapolis, IN
RecruitingPhase 1 / Phase 2NCT06582706
Nicotinic Acid for the Treatment of Alzheimer's Disease
Sponsor: Indiana University
Indianapolis, IN
RecruitingNot applicableNCT05733520
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
Sponsor: Indiana University
Indianapolis, IN
Not yet recruitingNot applicableNCT07779785
VICA: A Virtual Care Assistant for Dementia Caregivers
Sponsor: Indiana University
Indianapolis, IN
Not yet recruitingNot applicableNCT06045988
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's Disease
Sponsor: Indiana University
Indianapolis, IN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.